Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

NCT01239381 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01239381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2010
Completion date
September 1, 2017
Enrollment
92 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastases, solid tumor